Stock comparison
Boston Scientific
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
BSX
Boston Scientific
Market cap
$85.88B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | BSX | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 63C | 69B | MTD |
| Benjamin Graham | 69B | 65B | BSX |
| Philip Fisher | 70C | 63C | BSX |
| Peter Lynch | 58C | 66B | MTD |
| Joel Greenblatt | 44D | 68B | MTD |
| Charlie Munger | 54D | 74B | MTD |
| Terry Smith | 59D | 70B | MTD |
Side-by-side metrics
| Metric | BSX | MTD |
|---|---|---|
| Market cap | $85.88B | $22.29B |
| P/E (TTM) | 22.0x | 25.3x |
| EV/EBIT | 22.1x | 21.6x |
| ROIC (TTM) | 9.9% | 36.09% |
| Gross margin | 70.41% | 57.79% |
| Net margin | 17.24% | 21.4% |
| Revenue CAGR 5y | 13.99% | 2.01% |
| EPS CAGR 5y | 29.71% | 6.12% |
| Debt / Equity | 0.4x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BSX leads on
- Revenue CAGR 5y13.99%vs 2.01%+86%
- EPS CAGR 5y29.71%vs 6.12%+79%
- Market cap$85.88Bvs $22.29B+74%
- Gross margin70.41%vs 57.79%+18%
MTD leads on
- Debt / Equity-vs 0.4x+101%
- ROIC (TTM)36.09%vs 9.9%+73%
- Net margin21.4%vs 17.24%+19%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.